MARLBOROUGH, MA—Boston Scientific Corp. has agreed to buy rival BTG Corp. for $4.2 billion to expand its offering of medical devices to treat cancer and other disorders. Boston Scientific makes stents that hold open damaged blood vessels. BTG makes medical technology for physicians, such as cryoablation products to freeze and destroy diseased cells, and radiotherapy that delivers radiation straight to tumors.
